Navigation Links
HUYA Bioscience Int'l Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
Date:3/3/2008

Progress validates HUYA's innovative U.S./China pharmaceutical

co-development model

SAN FRANCISCO, March 3 /PRNewswire/ -- IBC Conference -- HUYA Bioscience International (HUYA), the leader in U.S./China pharmaceutical co-development, today announced the completion of three Phase I clinical trial protocols in China of a promising anti-arrhythmic compound, HBI-3000 (Sulcardine sulphate). The data from the trials support a desirable safety profile at dose levels displaying indications of pharmacologic activity. HBI-3000 is being developed as a potential treatment for both atrial and ventricular arrhythmias.

Anti-arrhythmic drugs are used today to treat patients with atrial fibrillation (AF), a serious condition that afflicts 5.6 million Americans. Anti-arrhythmic agents have also been used for the treatment of ventricular arrhythmias, although most have failed to demonstrate a survival advantage, and in some cases carry significant safety risk.

The main concern with anti-arrhythmic drugs is an increased risk of sudden death (Torsade de Pointes) in patients with underlying organic heart disease such as coronary artery disease, prior history of myocardial infarction and heart failure. A large subset of individuals with atrial and ventricular arrhythmias suffers from these conditions, precluding treatment with most existing anti-arrhythmic drugs. Development of safe anti-arrhythmic agents for use in these patients is needed. Pre-clinical data developed by HUYA and its Chinese partner, along with the Chinese clinical trial data suggest that HBI-3000 may have safety advantages over other anti-AF agents and exhibits broad spectrum ion channel inhibition without pro-arrhythmic activity that suggests it may also be safer to use in treatment of ventricular arrhythmias.

According to Mireille Gingras, Ph.D., CEO of HUYA, "the progress on this exciting new compound validates the efficiency and effectiveness of ou
'/>"/>

SOURCE HUYA Bioscience International
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments
2. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
3. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
4. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
5. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
6. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
7. Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis
8. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
9. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
10. Epiphany Biosciences Reports Initiation and Enrollment in Valomaciclovir Study for Shingles
11. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...A, Calif., Nov. 25 AMPAC Fine Chem...Corporation (Nasdaq: APFC ) announced today that ...ustainability Award at the Annual Statewide Enviro...cturers and Technology Association (CMTA), the Ind...emical Industry Council of California (CICC) held ...
(Date:11/25/2009)...K, Nov. 25 Reportlinker.com announ... in its catalogue: ,, Mammography Equipment -...eportlinker.com/p0164330/Mammography-Equipment---A...dence of breast cancer in industrialized as well a...cing growth in the mammography market. Globally, e...
(Date:11/25/2009)...IEGO, Nov. 25 NuVasive, ...cused on developing products for minimally disrupt...oday that it will host a conference call on Monday...T. The conference call will focus on current issu...ducts and will include comments from management fo...
Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4Chimerix Raises 2416 1 Million in Series E Financing 54158 1Chimerix Raises 2416 1 Million in Series E Financing 54158 2Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly 242 Billion in 2018 13490 1Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly 242 Billion in 2018 13490 2New Health Reform Campaign Will Support Long Term Care for All Because 3 in 4 Need More 54155 1New Health Reform Campaign Will Support Long Term Care for All Because 3 in 4 Need More 54155 2New Health Reform Campaign Will Support Long Term Care for All Because 3 in 4 Need More 54155 3
..., - Largest Genomic Study Comparing Gene Expressio...nual Meeting - , , ORLANDO, Fla., May 29 Genomic...sults from a study which summarized the gene signa...ncer test in a large number of male patients for w...otherapy. The results, which will be presented in ...
..., Panel Votes in Favor of Use by Physician/Nurse T...ion , , CINCINNATI, May 28 Ethicon Endo-Surgery ...atory Therapy Devices Advisory Committee of the U....or of approval of the SEDASYS(R) System for use by...derate propofol sedation during screening and diag...
Other Medicine Technology:Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 2Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 3Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 4Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 5FDA Advisory Panel Recommends Approval of the SEDASYS(R) System 2FDA Advisory Panel Recommends Approval of the SEDASYS(R) System 3
(Date:11/27/2009)..., KELOWNA, BC, Nov. 27 /PRNewswire/ - Uploadable U...ng prime time in wellness. A combination of advanc...upload are solving a long term concern over the ac... accurately gauge and reward improved participatio...ies is one of the first wellness suppliers to inte...
(Date:11/27/2009)..., NEUILLY-SUR-SEINE, France, Nov. 27 /PRNewswir...rofessional cycling team dedicated to ethical spor... champions, announced today that it will become Te...ions Optical as a new sponsor of the team. Transit...f adaptive eyewear, offering the most advanced pho...
(Date:11/27/2009)... , SEATTLE, Nov. 27 /PRNewswire/ -...ceived record-high Thanksgiving traffic numbers, w...Thanksgiving, providing a clear picture of what wa...The average Thanksgiving meal in 2009 weighed in a... from last year,s feast. According to the Allrecip...
(Date:11/26/2009)..., NEW YORK, Nov. 27 With cold and... to employ good practices to control the spread of...e proactive not only to keep ourselves healthy, bu...id Eileen Finerty, RN, MS, CIC (certified in infec...rol and occupational health at Hospital for Specia...
(Date:11/26/2009)...a bigger thrill when on an emotional rollercoaster...lthDay News) -- Call it the fear factor meets the ...t spectators -- especially those who root for the ... it,s a closely contested match and victory was in...ir. , Chew on that this Thanksgiving weekend as...
Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3
... National Multiple Sclerosis Society Mid Jersey ...s to create one NJ Metro Chapter. Registration is... New Jersey (PRWEB) November 7, 2...a world free of multiple sclerosis. The chapter is...
...mmer Holdings, Inc.,(NYSE: ZMH ; SWX: ZMH) announ...r of a new entity, created by the American Orthopa...t-graduate orthopaedic fellowships and,residency p...alyze funding requests before making grants to,edu...
...n of attention-deficit hyperactivity disorder, res...ay News) -- Very young children who sustain a head...tention-deficit hyperactivity disorder (ADHD) late... Nov. 8 online edition of the British Medical Jou...
...r of veterans with posttraumatic stress disorder (... consequences on families and children in communit...u, Ph.D., an expert on veteran mental health and a...D. The Department of Veterans Affairs (VA) has men...
...ERIS Corporation,(NYSE: STE ) is postponing its a...lower attendance than anticipated. The Company bel...tion of its shareholder base can,attend is the mos...S Corporation is a leading provider of infection p...
... MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: MBRK ...and commercializing novel anti-infective products,...atag (amoxicillin,extended-release) Tablets, 775mg...ok President & CEO John Thievon said, "Public Law ...
Other Medicine News:Health News:National Multiple Sclerosis Society New Jersey Metro Chapter Looking for People to Join the Movement 2Health News:National Multiple Sclerosis Society New Jersey Metro Chapter Looking for People to Join the Movement 3Health News:Zimmer Holdings to Collaborate with the American Orthopaedic Association for Funding Post-Graduate Medical Education 2Health News:Zimmer Holdings to Collaborate with the American Orthopaedic Association for Funding Post-Graduate Medical Education 3Health News:Head Injury in Young Kids May Predict ADHD Diagnosis 2Health News:Growing problem for veterans: Domestic violence 2Health News:STERIS Corporation Postpones Analyst Day 2Health News:STERIS Corporation Postpones Analyst Day 3Health News:MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents 2Health News:MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents 3Health News:MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents 4
ACCU-Beam® Coolpix Digital Camera Adaptor (30mm Eyepiece Adaptor)
ACCU-Beam® Universal Digital Camera Adaptor (Dual Adaptor)
ACCU-Beam® Universal Digital Camera Adaptor (23mm Eyepiece)
...cope Accessories includes digital camera adaptors,...les, and fiberoptic retrofits. The ACCU-Beam® ...a Zeiss® style beamsplitter port. Beamsplitter... other brands of microscopes, colposcopes and slit...
Medicine Products: